New monoamine antidepressant, hypidone hydrochloride (YL-0919), enhances the excitability of medial prefrontal cortex in mice via a neural disinhibition mechanism
- 22 November 2021
- journal article
- research article
- Published by Springer Nature in Acta Pharmacologica Sinica
- Vol. 43 (7) , 1699-1709
Abstract
Hypidone hydrochloride (YL-0919) is a novel antidepressant in clinical phase II trial. Previous studies show that YL-0919 is a selective 5-HT (serotonin) reuptake inhibitor, 5-HT1A receptor partial agonist, and 5-HT6 receptor agonist, which exerts antidepressant effects in various animal models, but its effects on neural function remain unclear. Medial prefrontal cortex (mPFC), a highly evolved brain region, controls highest order cognitive functions and emotion regulation. In this study we investigated the effects of YL-0919 on the mPFC function, including the changes in neuronal activities using electrophysiological recordings. Extracellular recording (in vivo) showed that chronic administration of YL-0919 significantly increased the spontaneous discharges of mPFC neurons. In mouse mPFC slices, whole-cell recording revealed that perfusion of YL-0919 significantly increased the frequency of sEPSCs, but decreased the frequency of sIPSCs. Then we conducted whole-cell recording in mPFC slices of GAD67-GFP transgenic mice, and demonstrated that YL-0919 significantly inhibited the excitability of GABAergic neurons. In contrast, it did not alter the excitability of pyramidal neurons in mPFC slices of normal mice. Moreover, the inhibition of GABAergic neurons by YL-0919 was prevented by pre-treatment with 5-HT1A receptor antagonist WAY 100635. Finally, chronic administration of YL-0919 significantly increased the phosphorylation levels of mTOR and GSK-3β in the mPFC as compared with vehicle. Taken together, our results demonstrate that YL-0919 enhances the excitability of mPFC via a disinhibition mechanism to fulfill its rapid antidepressant neural mechanism, which was accomplished by 5-HT1A receptor-mediated inhibition of inhibitory GABAergic interneurons.Keywords
This publication has 51 references indexed in Scilit:
- Burst‐firing patterns in the prefrontal cortex underlying the neuronal mechanisms of depression probed by antidepressantsEuropean Journal of Neuroscience, 2014
- Activation of muscarinic receptors inhibits glutamate-induced GSK-3β overactivation in PC12 cellsActa Pharmacologica Sinica, 2013
- A prefrontal cortex–brainstem neuronal projection that controls response to behavioural challengeNature, 2012
- Heterodimerization of serotonin receptors 5-HT1A and 5-HT7 differentially regulates receptor signalling and traffickingJournal of Cell Science, 2012
- 5-HT1A Receptor Agonists Enhance Pyramidal Cell Firing in Prefrontal Cortex Through a Preferential Action on GABA InterneuronsCerebral Cortex, 2011
- mTOR-Dependent Synapse Formation Underlies the Rapid Antidepressant Effects of NMDA AntagonistsScience, 2010
- Prenatal stress and subsequent exposure to chronic mild stress influence dendritic spine density and morphology in the rat medial prefrontal cortexBMC Neuroscience, 2007
- Stress, Depression, and Neuroplasticity: A Convergence of MechanismsNeuropsychopharmacology, 2007
- Volumetric Analysis of the Prefrontal Cortex, Amygdala, and Hippocampus in Major DepressionNeuropsychopharmacology, 2003
- Is there a role for 5-HT1A agonists in the treatment of depression?Biological Psychiatry, 2003